TY - JOUR
T1 - B-type natriuretic peptide is not a prognostic marker in acute dyspneic patients with renal insufficiency
AU - Ahn, Min Soo
AU - Yoo, Byung Su
AU - Lee, Jun Won
AU - Lee, Ji Hyun
AU - Youn, Young Jin
AU - Ahn, Sung Gyun
AU - Kim, Jang Young
AU - Lee, Seung Hwan
AU - Yoon, Junghan
N1 - Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 2014
Y1 - 2014
N2 - Objective: The prognostic value of BNP levels in patients presenting with acute dyspnea and renal insufficiency (RI) has been questioned. We evaluated the long-term prognostic value of BNP levels in dyspneic patients with RI. Methods: Of 1,207 consecutive participants who presented with acute dyspnea, patients with mild-to-severe RI (152) were recruited. During follow-up, major adverse events (MAEs), i.e., all causes of death and rehospitalization, because of worsening heart failure were evaluated. Results: A total of 408 patients with acute dyspnea and RI were evaluated. During a 30.1± 31.7-month follow-up, cardiac death (n=26), non-cardiac death (n=28) and hospital re-admission (n=117) was observed in 35% of patients (n=143). The adjusted multiple Cox regression analysis showed that left atrial diameter was a significant prognostic maker of MAEs (relative risk, 1.18; 95% confidence interval, 1.03-1.34; p=0.02). Conclusions: We focused on subjects with acute dyspnea and renal failure who required hospital admission, BNP level was not a prognostic marker but left atrial diameter as a surrogate marker of diastolic dysfunction was an independent prognostic maker of all cause of death and rehospitalization due to aggravated heart failure.
AB - Objective: The prognostic value of BNP levels in patients presenting with acute dyspnea and renal insufficiency (RI) has been questioned. We evaluated the long-term prognostic value of BNP levels in dyspneic patients with RI. Methods: Of 1,207 consecutive participants who presented with acute dyspnea, patients with mild-to-severe RI (152) were recruited. During follow-up, major adverse events (MAEs), i.e., all causes of death and rehospitalization, because of worsening heart failure were evaluated. Results: A total of 408 patients with acute dyspnea and RI were evaluated. During a 30.1± 31.7-month follow-up, cardiac death (n=26), non-cardiac death (n=28) and hospital re-admission (n=117) was observed in 35% of patients (n=143). The adjusted multiple Cox regression analysis showed that left atrial diameter was a significant prognostic maker of MAEs (relative risk, 1.18; 95% confidence interval, 1.03-1.34; p=0.02). Conclusions: We focused on subjects with acute dyspnea and renal failure who required hospital admission, BNP level was not a prognostic marker but left atrial diameter as a surrogate marker of diastolic dysfunction was an independent prognostic maker of all cause of death and rehospitalization due to aggravated heart failure.
UR - http://www.scopus.com/inward/record.url?scp=84903724977&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84903724977&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:84903724977
VL - 20
SP - 3755
EP - 3769
JO - Experimental and Clinical Cardiology
JF - Experimental and Clinical Cardiology
SN - 1205-6626
IS - 6
ER -